Morgan Stanley Champions Oncology, Inc. Transaction History

Morgan Stanley

$1.59 Trillion
Q3 2025

A detailed history of Morgan Stanley transactions in Champions Oncology, Inc. stock. As of the latest transaction made, Morgan Stanley holds 189,600 shares of CSBR stock, worth $1.29 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

189,600

Previous 130,500 45.29%

Holding current value

$1.29 Million

Previous $961,000 26.01%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$6.16 - $8.91 $364,056 - $526,581	59,100 Added 45.29%	189,600 $1.21 Million
Q2 2025 Aug 15, 2025	BUY	$5.72 - $8.85 $240,628 - $372,301	42,068 Added 47.57%	130,500 $961,000
Q1 2025 May 15, 2025	BUY	$8.2 - $11.7 $127,362 - $181,724	15,532 Added 21.31%	88,432 $767,000
Q4 2024 Feb 14, 2025	BUY	$3.79 - $8.62 $57,229 - $130,161	15,100 Added 26.12%	72,900 $624,000
Q3 2024 May 14, 2025	BUY	$3.95 - $5.14 $58,065 - $75,558	14,700 Added 34.11%	57,800 $281,000
Q3 2024 Nov 14, 2024	BUY	$3.95 - $5.14 $58,065 - $75,558	14,700 Added 34.11%	57,800 $281,000
Q2 2024 May 14, 2025	SELL	$4.5 - $5.23 $134,100 - $155,854	-29,800 Reduced 40.88%	43,100 $222,000
Q2 2024 Oct 17, 2024	BUY	$4.5 - $5.23 $10,800 - $12,552	2,400 Added 5.9%	43,100 $222,000
Q2 2024 Aug 14, 2024	BUY	$4.5 - $5.23 $10,800 - $12,552	2,400 Added 5.9%	43,100 $222,000
Q1 2024 Oct 17, 2024	SELL	$4.9 - $6.91 $11,760 - $16,584	-2,400 Reduced 5.57%	40,700 $199,000
Q1 2024 Aug 16, 2024	BUY	$4.9 - $6.91 $154,840 - $218,356	31,600 Added 347.25%	40,700 $199,000
Q1 2024 May 15, 2024	BUY	$4.9 - $6.91 $154,840 - $218,356	31,600 Added 347.25%	40,700 $199,000
Q4 2023 Aug 16, 2024	SELL	$4.56 - $6.59 $155,040 - $224,060	-34,000 Reduced 78.89%	9,100 $51,000
Q4 2023 Feb 13, 2024	SELL	$4.56 - $6.59 $9,120 - $13,180	-2,000 Reduced 18.02%	9,100 $51,000
Q2 2023 Aug 14, 2023	BUY	$4.11 - $6.81 $8,220 - $13,620	2,000 Added 21.98%	11,100 $70,000
Q1 2023 May 15, 2023	BUY	$4.0 - $4.67 $4,824 - $5,632	1,206 Added 15.28%	9,100 $36,000
Q4 2022 Feb 14, 2023	BUY	$3.75 - $7.69 $352 - $722	94 Added 1.21%	7,894 $35,000
Q3 2022 Nov 14, 2022	BUY	$7.21 - $9.47 $17,304 - $22,728	2,400 Added 44.44%	7,800 $59,000
Q2 2022 Oct 27, 2022	SELL	$6.81 - $8.31 $9,574 - $11,683	-1,406 Reduced 20.66%	5,400 $43,000
Q2 2022 Aug 15, 2022	SELL	$6.81 - $8.31 $9,574 - $11,683	-1,406 Reduced 20.66%	5,400 $43,000
Q1 2022 Oct 27, 2022	BUY	$7.26 - $8.53 $10,207 - $11,993	1,406 Added 26.04%	6,806 $55,000
Q1 2022 May 13, 2022	SELL	$7.26 - $8.53 $5,285 - $6,209	-728 Reduced 9.66%	6,806 $55,000
Q4 2021 Feb 14, 2022	BUY	$7.76 - $10.23 $4,725 - $6,230	609 Added 8.79%	7,534 $63,000
Q3 2021 Nov 15, 2021	BUY	$9.11 - $10.96 $63,086 - $75,898	6,925 New	6,925 $70,000

Others Institutions Holding CSBR

# of Institutions

Shares Held

5.69M

Call Options Held

Put Options Held

View Full List

About CHAMPIONS ONCOLOGY, INC.

Ticker CSBR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,522,400
Market Cap $91.8M
Description
Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Techn...

More about CSBR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account